BRCA1 and breast carcinoma: Although BRCA1 mutation is linked to increased risk of breast cancer [9] and nonphysiological overexpression of BRCA1 induces apoptosis [10], recent research showed that reduced BRCA1 expression resulted in decreased viability of MDA-MB-231 cells [11], suggesting functional BRCA1 as a therapeutic target.